Phoenix7's Stock Sizzlers

[riverbabe]

I thought the drop had to do with the situation in Iraq and worries about fuel prices. Mayhap not.

And those too.

[Phoenix7]

Ladies thank you for all your comments , I am currently not invested in the air lines, but I am sure your posts will help others! Question..... are you ladies in ETRM? As we all know ETRM is a gamble , but if successful thousands of obese people can lead better lives.

[riverbabe]

Ladies thank you for all your comments , I am currently not invested in the air lines, but I am sure your posts will help others! Question..... are you ladies in ETRM? As we all know ETRM is a gamble , but if successful thousands of obese people can lead better lives.

This from Adam Feuerstein of thestreet.com: (he has a good track record of being right) "EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel
BY Adam Feuerstein 06/12/14 - 08:00 AM EDT


NEW YORK (TheStreet) -- EnteroMedics (ETRM_) and its VBLOC "fat-zapping" implantable medical device will be the focus of an FDA advisory panel meeting next Tuesday, June 17. If FDA follows historical form, the agency's review of VBLOC's safety and efficacy will be available publicly tomorrow morning.

I'm eager to read the FDA review to see how the agency interprets data from two clinical trials in which obese patients on VBLOC therapy failed to achieve statistically significant "excess weight loss" compared to patients implanted with a sham devices. EnteroMedics is seeking FDA approval of VBLOC on the basis of two studies which failed their respective primary efficacy endpoints. This seems like a Hail Mary regulatory strategy, but EnteroMedics argues for a more holistic view of the VBLOC data: Sure, the pre-specified efficacy endpoints of the studies were not met, the company argues, but VBLOC-treated patients still lost weight and the pacemaker-like device is safe, so it should be approved.

Normally, I'd say EnteroMedics has a low single-digit probability of convincing the experts on Tuesday's panel to recommend approval, but VBLOC is a medical device. Anyone who follows the FDA and medical device reviews knows strange things can (and often do) happen. (Remember Mela Sciences (MELA_)?) If the FDA review of VBLOC tomorrow is relatively benign, EnteroMedics just might have a decent shot at a positive panel vote, despite the device's mediocre weight-loss profile.

Of course, if FDA slams VBLOC, EnteroMedics will be in a heap of trouble Tuesday..." http://www.thestreet.com/story/12741...fda-panel.html

(too much risk for me)

[Phoenix7]

Latest ETRM news from a "YAHOO" Poster and the ETRM saga continues! GO ETRM!!


"Read the Briefing Report; Will be APPROVED, here is why....

The protocol prepared by the FDA is flawed and is to show why. In the protocol the FDA assumed that the VBLOC would hit 25% EWL loss and sham group 5% EWL loss hence a 20% target was put as realistic.

The assumption made by FDA in the protocol is wrong as sham group hit 15% where-as VBLOC did hit their 25% target.

Now whose fault is it? It is not ETRM as the protocol is designed by the FDA. If the primary assumption is incorrect the sham group (placebo) then the beginning comparative point cannot be maintained.

If the FDA had correctly put the placebo assumption at 15% then it would have required VBLOC only to hit 10% difference and, not 20%. The primary assumption was wrong. The rest of the report is fine.

I say approval for the following reason:

The Maestro Rechargeable System provides a new option for patients who are seeking
clinically significant weight loss.

As described in this document, the Maestro Rechargeable System is a safe and effective treatment option for obese individuals who have failed more conservative weight reduction interventions such as diet/exercise and pharmacotherapy, but are not able or willing to undergo more aggressive bariatric surgical options.

Obesity in the United States has reached epidemic levels. Two of every three adults in the U.S. are either obese or overweight. One of the most significant challenges facing clinicians in treating obese patients is the limited number of safe, effective, and acceptable treatment options. "

I like this guys opinion , but the decision will be revealed next week!

[noshadyldy]

Latest ETRM news from a "YAHOO" Poster and the ETRM saga continues! GO ETRM!!


"Read the Briefing Report; Will be APPROVED, here is why....

The protocol prepared by the FDA is flawed and is to show why. In the protocol the FDA assumed that the VBLOC would hit 25% EWL loss and sham group 5% EWL loss hence a 20% target was put as realistic.

The assumption made by FDA in the protocol is wrong as sham group hit 15% where-as VBLOC did hit their 25% target.

Now whose fault is it? It is not ETRM as the protocol is designed by the FDA. If the primary assumption is incorrect the sham group (placebo) then the beginning comparative point cannot be maintained.

If the FDA had correctly put the placebo assumption at 15% then it would have required VBLOC only to hit 10% difference and, not 20%. The primary assumption was wrong. The rest of the report is fine.

I say approval for the following reason:

The Maestro Rechargeable System provides a new option for patients who are seeking
clinically significant weight loss.

As described in this document, the Maestro Rechargeable System is a safe and effective treatment option for obese individuals who have failed more conservative weight reduction interventions such as diet/exercise and pharmacotherapy, but are not able or willing to undergo more aggressive bariatric surgical options.

Obesity in the United States has reached epidemic levels. Two of every three adults in the U.S. are either obese or overweight. One of the most significant challenges facing clinicians in treating obese patients is the limited number of safe, effective, and acceptable treatment options. "

I like this guys opinion , but the decision will be revealed next week!

i hope soon. I'm taking a beating every day on this one.

[Phoenix7]

i hope soon. I'm taking a beating every day on this one.

NSL I know how you feel ......I feel like a punching bag myself some days LOL Better Days are coming!

ETRM LONGS Read This: As Dr. Scott Shikora, director of the Center for Metabolic and Bariatric Surgery at Brigham and Women’s Hospital, tells readers of The Boston Globe:

“The prospect of being able to control one’s appetite yet still be free from a strict diet-control regimen should be appealing to millions of severely obese Americans who haven’t [yet] responded to the plethora of weight-loss remedies offered [to] them during the nation’s four-decades-old “war on obesity” and those that are fearful of bariatric surgery. This is a real breakthrough in the stepped-up war on obesity. This device has very low risk, allows patients to eat most [of all] the food they normally eat and can even be turned off for brief respites (such as a pregnancy). It is designed to be reversible, programmable and adjustable from outside the body.”

[Phoenix7]

My Market Trend Signals is indicating a "SELL" for PALL ........Time to SHORT THIS BABY! Look at the chart and PALL appears to headed for DOWN Davy Jones' Locker http://finviz.com/quote.ashx?t=pall&ty=c&ta=1&p=d

[Phoenix7]

Father's Day Super Sunday Stock Spectaculars.

To all the dads out there, "HAPPY FATHER'S DAY!" . May God bless you all, and best wishes for health, wealth and happiness throughout your lives.
Without further ado I shall dispense with a plethora of verbal diarrhea and give you the picks straight up. As always additional comments will be added at random intervals.

1. ANTH http://finviz.com/quote.ashx?t=anth&ty=c&ta=1&p=d

2. BMY http://finviz.com/quote.ashx?t=bmy&ty=c&ta=1&p=d

3. CELG http://finviz.com/quote.ashx?t=celg&ty=c&ta=1&p=d

4. DRTX http://finviz.com/quote.ashx?t=drtx&ty=c&ta=1&p=d Durata Therapeutics CEO buys 3,000 shares
Durata Therapeutics CEO Paul Edick purchased 3,000 shares of the company's stock at a price of $15.23 each on June 12, according to a regulatory filing. DRTX received FDA Approval for its antibiotic drug Dalvance in late May! This should generate some revenue READ THIS http://finance.yahoo.com/news/durata...193005255.html

5. ETRM FOLKS Remember that ETRM is a Risky Stock and if the FDA advisory committee renders a negative decision on June 17, 2014 ETRM,s Maestro's Weight reduction medical device ETRM stock could drop dramatically , but if they give it thumbs up..... GAINS could be HUGE! Read This : ETRM Has some good news" EnteroMedics Inc. (NASDAQ: ETRM) has a huge binary event scheduled for June 17. An FDA panel will discuss its neuroblocking device that is used to help in the treatment for obesity. At an FDA panel, companies meet with assembled experts and usually with the aim of presenting positive clinical trial information and data. Typically then the panel will vote up or down on the drug or product. This is not to be confused with FDA approval meeting. Typically, FDA officials will take the panels' recommendations under consideration, but even if the vote is negative, it does not mean approval will not happen. Regional boutique firm Craig-Hallum is bullish on the stock and the company's chances at the upcoming panel. The firm has a $6 price target on the stock, and the consensus target is $4.80. Shares closed at $1.62 Friday afternoon"
Here is chart of the 6/9/14 Close http://finviz.com/quote.ashx?t=etrm&ty=c&ta=1&p=d 2nd Chart: http://scharts.co/1uNNUZk
See Analysts 12 Month Estimates : http://money.cnn.com/quote/forecast/...html?symb=ETRM

6. EXEL http://finviz.com/quote.ashx?t=exel&ty=c&ta=1&p=d http://seekingalpha.com/article/2107...-the-near-term

7. GILD http://finviz.com/quote.ashx?t=gild&ty=c&ta=1&p=d

8. GPRE http://finviz.com/quote.ashx?t=gpre&ty=c&ta=1&p=d

9. THRX Biopharma stocks are risky, but there are some that act as drug royalty companies.
THRX is one of them. What Does This Company Do?
Theravance Inc., is a biopharmaceutical company with a pipeline of internally discovered product candidates and collaborations with pharmaceutical companies.
THRX has no manufacturing facilities, no expensive research operations yet manages to collect a steady stream of royalty checks. They will begin paying a 25 Cent Dividend this quarter, and future growth prospects for the company look good.
Perhaps this is one to buy and tuck away into a Roth Ira.
THRX Chart: http://finviz.com/quote.ashx?t=thrx&ty=c&ta=1&p=d 2nd Chart http://scharts.co/TLHP2r

10. ZQK http://finviz.com/quote.ashx?t=gpre&ty=c&ta=1&p=d Folks "HEAVY" Insider buying of ZQK , also READ this: http://www.thestreet.com/story/12738...m_ven=CNNMONEY 2nd ZQK Chart: http://scharts.co/1i0oK7e Folks the "Pincher" Set Up Is forming For ZQK and once that takes hold $6 is plausible for ZQK! Time to buy now on the cheap!


FATHER'S DAY BONUS PICK BDSI A former pick of mine that is lookin' GOOD BioDelivery Sciences could be bought by Endo, says Summer Street
Summer Street sees shares of BioDelivery Sciences (BDSI) heading to the $15 level on positive buprenorphine data in July, a drug the company partners with Endo (ENDP). The firm notes Endo could owe up to $70M in milestones to BioDelivery, but it finds it more likely that Endo buys BioDelivery outright. Summer Street keeps a Buy rating on the stock with a $20 price target

BDSI Chart http://finviz.com/quote.ashx?t=bdsi&ty=c&ta=1&p=d

[Phoenix7]

Folks this 2 minute video will "SHOW" you why ETRM's Fat Reduction Device should pass the FDA Advisory committee........just look around OBESITY is a serious problem NO JOKE!

https://www.youtube.com/watch?v=RN_VwMb8m2M

ETRM in after hours trading is UP slightly. Since the FDA Advisory Committee is deciding the fate of ETRM Tomorrow . There will be NO trading in ETRM stock Tuesday 6/17/14 WEDNESDAY will be an interesting day!

Folks here is a LINK to a "LIVE FEED" From the FDA Advisory Committee hearings. UPDATES are given periodically http://finance.yahoo.com/mbview/thre...la%2Cd%2C0%2C3

A YAHOO POSTER SUMMARIZES THE FDA AD COM VOTE! ON ETRM:

" An FDA advisory panel votes overall that the benefits of EnteroMedics' Maestro weight-loss implant outweigh the risks, but panel members have some concerns about the effectiveness of the device.
FLASH: FDA panel issues mixed vote on EnteroMedics weight-loss implant

EnteroMedics (NSDQ:ETRM) got a mixed bag of support from a panel of FDA advisors today, with most panelists voting that the company's weight-loss implant is safe but raising concerns about the effectiveness of the device.

The 9-member panel voted that EnteroMedics' Maestro nerve-stimulation implant is safe (8 to 1) and that the overall benefits outweigh the risks (6 to 2 with 1 abstention), but the panel was split on whether the device is effective (5 no, 4 yes). The FDA isn't bound by the recommendations of its advisory panels, but the federal watchdog agency usually sides with them"

What happens tomorrow to the Stock Price for ETRM?...........Your guess is as good as mine.

[Phoenix7]

ETRM's fate will be determined at 9:30 when the stock market opens for business. Hopefully we will get a nice pop UP!

While waiting be sure to check out ZQK. A close associate of mine who has intimate knowledge of the clothing industry told me ZQK is way over sold , and with heavy recent insider buying 6 BUCKS could be a target for ZQK Look Here http://finviz.com/quote.ashx?t=zqk&ty=c&ta=1&p=d I do have a position in ZQK.

I am Watching QTWW because it scored a perfect 100 on my Market Trend Signal System Look Here http://finviz.com/quote.ashx?t=qtww&ty=c&ta=1&p=d Gezzzzzzzlook at the baby move! Although I would wait for a pullback!

[Louetta]

ETRM's fate will be determined at 9:30 when the stock market opens for business. Hopefully we will get a nice pop UP!

While waiting be sure to check out ZQK. A close associate of mine who has intimate knowledge of the clothing industry told me ZQK is way over sold , and with heavy recent insider buying 6 BUCKS could be a target for ZQK Look Here http://finviz.com/quote.ashx?t=zqk&ty=c&ta=1&p=d I do have a position in ZQK.

I am Watching QTWW because it scored a perfect 100 on my Market Trend Signal System Look Here http://finviz.com/quote.ashx?t=qtww&ty=c&ta=1&p=d Gezzzzzzzlook at the baby move! Although I would wait for a pullback!

ETRM up 22% in the pre-market.

[Phoenix7]

ETRM up 22% in the pre-market.

Louetta We will have to see how ETRM closes . Supposedly a load of $2.50 Call options were sold and expire on Friday. Friday should be an interesting day! Here is a nice diagram that shows hows how electrodes from the device are attached to the Vagus nerve. Interesting Look Here http://www.cbsnews.com/news/fda-pane...t-loss-device/

[Phoenix7]

ZACK'S Wrote a negative report on ETRM. ZACKS is getting more and more like Seeking Alpha. A Yahoo poster comments on the ETRM negative report!
" Same Recycled Zacks Hachet Job As June 6
Maybe they think nobody noticed but this is the same Zacks hachet job as June 6 & is starting to become obvious. Meanwhile of 10 covering analysts sourced by Thomson/First Call & listed right here on Yahoo stock screen, there are 3 Strong Buys, 3 Buys, 4 Holds, No Underperforms, & No SELLS. Makes me question Zacks agenda."
ZACKS was trying to entice me to pay for their premium service ....WHY? Much Better Stock tips can be found right here on Mr Market Is Huge!

[Phoenix7]

The Case For Theravance THRX . On June 3, 2014 Theravance split into 2 companies TBPH and THRX with a resulting 22% Drop in price. NOW here is where the story becomes verrrrrrrry interesting . TBPH is still basically a research Bio Pharma with all the inherent risks and expenses, while THRX is basically a drug royalty company , with NO research facilities, no manufacturing plants , but they get a constant stream of cash coming in, and more importantly very little cash flowing out.
THRX will begin paying a 25 cent dividend for every share you own before 9/20/14.
They will be in the business of buying pieces of new drugs to add to their stable.
Dividends are expected to INCREASE as more money cascades in from their royalty programs.
15% to 20% returns per year plus a 4% dividend look probable.

Folks THRX looks like a no brainer to me , and I do own a position in the company, and I expect THRX to rise considerably from its current price.

Here is a link to an article on the THRX split up into 2 companies : http://www.fool.com/investing/genera...t-appears.aspx

THRX CHART: http://finviz.com/quote.ashx?t=thrx&ty=c&ta=1&p=d
Folks I do not subscribe to the Motley Fools , and I DO NOT endorse them. Why bother paying when you can come to www.mrmarketishuge.com and get all the information you need FOR FREE!

ETRM One down and one to go . FDA Advisory Committee Approved ETRM's Maestro Fat Reduction Device. Now we must await the FDA Panel's Decision, and hopefully it too will be positive.
ETRM is slowly climbing today , and read this : ETRM Upgraded by Roth Capital today - $5 Target ALSO 2 others both Conncord and Yahoo Finance have set $5 Targets. Folks yes it is still a gamble , but if the FDA Panel gives it a nod you will be kicking yourself in the ass for not buying while it is still cheap! ETRM Chart

Look at the ETRM UPDATES: 6/18/2014 - Roth Capital Boost - Price Target - Buy - $5.00
6/16/2014 - Canaccord Genuity - Boost Price Target - Buy - $5.00
4/21/2014 - Northland Securities - Reiterated Rating - Buy -
01/6/2014 - Craig Hallum - Boost Price Target - - $6.00

Great Link You Can Actually Enter your own stocks

http://www.investorguide.com/stock-analysis.php?ticker=ETRM

Watch THRX entered into the box.......NOTE the $42 High Yes folks THRX could possibly hit $42 and beyond http://www.investorguide.com/stock-a...hp?ticker=THRX

[Phoenix7]

Yahoo Just raised the ETRM Price. Yahoo Finance RAISED 1 yr target from $5 to $5.40 a share. Go ETRM.

ETRM $2.50 Call Options will probably expire tomorrow. It is doubtful that the Market Makers will let ETRM rise above $2.50 tomorrow, thay prefer for the options to expire worthless , which is money in their pocket!